Dogwood Therapeutics Inc (DWTX): DWTX LONG😎💰 HC Wainwr...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Dogwood Therapeutics Inc (DWTX)

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	205
Posts	15015
Boards Moderated	3
Alias Born	04/03/2007

Re: None

Tuesday, 03/03/2026 8:13:08 AM

Tuesday, March 03, 2026 8:13:08 AM

DWTX LONG😎💰

HC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

Bullish

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent DWTX News

Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 01:00:12 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2026 08:30:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2026 01:00:22 PM
Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:30:18 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:20:01 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:16:38 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/13/2026 09:05:34 PM
Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026 • GlobeNewswire Inc. • 02/02/2026 01:30:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/30/2026 05:15:21 AM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 01/23/2026 09:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 01:30:09 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/15/2026 09:19:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2026 05:38:14 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/13/2026 05:06:04 PM
Dogwood Therapeutics, Inc. Announces Financing of up to $26.8 Million to Progress Halneuron® Through Phase 2b Development • GlobeNewswire Inc. • 01/12/2026 01:30:00 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2026 09:10:38 PM
Dogwood Therapeutics Announces Positive Interim Phase 2b Clinical Trial Results in Chemotherapy Induced Neuropathic Pain • GlobeNewswire Inc. • 12/22/2025 03:15:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:05:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:05:12 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:05:10 PM
Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045 • ACCESS Newswire • 12/02/2025 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2025 07:15:10 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/28/2025 07:00:50 PM

More DWTX News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow